Are we expecting income?
It was announced prior to cap raising cvac has been granted approval for commercialization in the middle east.
"Significant opportunity for Prima to tap into US$517 million Middle East cancer therapy market."
"First commercial sales of CVac anticipated in 2011."
The first is a very open statement, how much of this market estimation is related to ovarian cancer therapy?
1mil, 5mi, 15mil, 50mil?
The later, anticipates sales during 2011. Assuming PRR brings in revenue. Will these figures appear in the next round of financial reportings?
It would be great to see some revenue so early from the main drug, even if it was only a few million.
Are we expecting income?It was announced prior to cap raising...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.020(6.90%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.5¢ | 29.0¢ | $1.805M | 5.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 193400 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |